263 related articles for article (PubMed ID: 11363751)
1. Editorial: time to end the death trials.
James JS
AIDS Treat News; 1996 Aug; (no 252):1-4. PubMed ID: 11363751
[TBL] [Abstract][Full Text] [Related]
2. FDA evaluates accelerated approval process. Food and Drug Administration.
Common Factor; 1995 Apr; (no 10):18. PubMed ID: 11362343
[TBL] [Abstract][Full Text] [Related]
3. AIDS task force grapples with faster access to protease drugs.
Mascolini M
J Int Assoc Physicians AIDS Care; 1995 Mar; 1(2):6-11. PubMed ID: 11362314
[TBL] [Abstract][Full Text] [Related]
4. Potent new AIDS drugs underscore promise of combination therapy.
AIDS Alert; 1996 Jan; 11(1):1-4. PubMed ID: 11363225
[TBL] [Abstract][Full Text] [Related]
5. FDA triple header. Food and Drug Administration.
Smart T
GMHC Treat Issues; 1995 Nov; 9(11):1-3. PubMed ID: 11362986
[TBL] [Abstract][Full Text] [Related]
6. FDA antiviral advisory hearings on lamivudine (Epivir, 3TC), saquinavir (Invirase), stavudine (Zerit, d4T), November 6-8. Food and Drug Administration.
AIDS Treat News; 1995 Oct; (no 233):4-5. PubMed ID: 11363038
[TBL] [Abstract][Full Text] [Related]
7. AIDS activists seek speedy access to protease drugs...
Gavaghan H
Nature; 1995 Mar; 374(6517):4. PubMed ID: 7870168
[No Abstract] [Full Text] [Related]
8. FDA workshop on clinical trial design, September 6-7--registration by Aug. 18. Food and Drug Administration.
James JS
AIDS Treat News; 1995 Aug; (no 228):5-6. PubMed ID: 11362627
[TBL] [Abstract][Full Text] [Related]
9. HIV therapeutics, continued: another HIV protease inhibitor approved.
Laurence J
AIDS Read; 2003 Aug; 13(8):355-6. PubMed ID: 14524318
[No Abstract] [Full Text] [Related]
10. Three drug combo halves AIDS deaths.
Treat Rev; 1997 Apr; (No 24):2-4. PubMed ID: 11364283
[TBL] [Abstract][Full Text] [Related]
11. New drug approved to treat HIV.
Treat Rev; 1997 Apr; (No 24):5. PubMed ID: 11364284
[TBL] [Abstract][Full Text] [Related]
12. Merck protease inhibitor available to persons with CD4 count 50 or less--must register by August 11.
AIDS Treat News; 1995 Jul; (no 227):1-2. PubMed ID: 11362618
[TBL] [Abstract][Full Text] [Related]
13. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
[TBL] [Abstract][Full Text] [Related]
14. Europeans outraged over expanded access.
Alcorn K; Nary G; Pernet AG; Surchio JL; Weiner JD
J Int Assoc Physicians AIDS Care; 1996 Apr; 2(4):48-51. PubMed ID: 11363519
[TBL] [Abstract][Full Text] [Related]
15. Protease inhibitors and beyond: interview with David Feigal, M.D. Interview by John S James.
Feigal D
AIDS Treat News; 1995 Mar; (no 219):1-6. PubMed ID: 11362331
[TBL] [Abstract][Full Text] [Related]
16. Update on issues for HIV management.
Bradford D
Aust Fam Physician; 1997 Jul; 26(7):812-7. PubMed ID: 9232919
[TBL] [Abstract][Full Text] [Related]
17. Let there be drugs.
Gilden D
GMHC Treat Issues; 1996 Feb; 10(2):1, 13-6. PubMed ID: 11363380
[TBL] [Abstract][Full Text] [Related]
18. Expert panel to update 'obsolete' guidelines.
AIDS Alert; 1995 Nov; 10(11):136. PubMed ID: 11362923
[TBL] [Abstract][Full Text] [Related]
19. FDA community meeting May 16: clinical trials and viral load. Food and Drug Administration.
AIDS Treat News; 1997 May; (No 270):3. PubMed ID: 11364324
[TBL] [Abstract][Full Text] [Related]
20. FDA expands testing of anti-AIDS drugs.
N Y State J Med; 1989 Sep; 89(9):548. PubMed ID: 2552360
[No Abstract] [Full Text] [Related]
[Next] [New Search]
